Ferrannini, Giulia
Pollock, Carol
Natali, Andrea
Yavin, Yshai
Mahaffey, Kenneth W.
Ferrannini, Ele
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 5 January 2023
Accepted: 12 April 2023
First Online: 29 April 2023
Declarations
:
: The trialsĀ“ protocols were approved by the ethics committees at each site (ClinicalTrials.gov NCT01032629, NCT01989754 and NCT02065791). All participants provided informed, written consent nand the trials were carried out according to the Declarations of Helsinki.
: Not applicable.
: YY is an employee of Janssen Research & Development, LLC. EF holds a research grant from Janssen, has held research grants from Boehringer-Ingelheim and has received consultancy or speaker fees from Sanofi, Boehringer Ingelheim, ORAMED, and Lilly & Co.
: The other authors have no conflicts of interest to disclose related to this work.